Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM198A Inhibitors

FAM198A, short for Family with Sequence Similarity 198 Member A, is a protein that has not been extensively characterized in terms of its biological function. The term "FAM" indicates that it belongs to a particular family of proteins that share sequence similarity, suggesting potential shared structural features or functional roles.The human FAM198A gene is located on chromosome 17, and the protein it encodes is expressed in multiple tissues, which implies a role in fundamental cellular processes. The exact role of FAM198A in these tissues, however, remains to be fully elucidated.

Bioinformatics analyses often predict potential functions for proteins like FAM198A based on their sequence similarity to other proteins with known functions, domain architecture, and expression patterns. For instance, if FAM198A contains domains that are typical of enzymes, it might be involved in catalytic processes within the cell. Alternatively, if it contains domains known for protein-protein interactions, it could play a role in signaling pathways or the assembly of protein complexes.The study of FAM198A could involve various experimental approaches, such as gene knockdown or knockout models to determine its role in cell biology and physiology. Additionally, protein interaction assays could be used to identify binding partners and place FAM198A within specific cellular pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR, a key regulator of protein synthesis, potentially affecting FAM198A-related processes.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

Everolimus, an mTOR inhibitor, may indirectly influence FAM198A function by altering protein synthesis regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002, a PI3K inhibitor, could indirectly affect FAM198A by modulating the PI3K/AKT/mTOR pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin, a potent PI3K inhibitor, may have an indirect impact on FAM198A through the PI3K/AKT pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059, an inhibitor of MEK, which is upstream of ERK, might affect FAM198A-related signaling indirectly.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125, a JNK inhibitor, might have indirect effects on FAM198A through stress and cytokine signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580, a p38 MAPK inhibitor, could indirectly influence FAM198A activity through MAPK pathway regulation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

Sorafenib, a multi-kinase inhibitor, might indirectly affect FAM198A by targeting various signaling pathways.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Sunitinib, with its broad tyrosine kinase inhibition, could potentially impact FAM198A-associated pathways.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib, primarily a BCR-ABL inhibitor, may have broader effects potentially impacting FAM198A's role.